Hemab Reports Sutacimig Cut Prothrombin Time by Over 50% in Two Participants

Two participants with severe congenital Factor VII deficiency received one sutacimig dose, and both had prothrombin time shorten by more than 50%. One participant with available data showed approximately 5x accumulation of endogenous FVII(a) through Day 22.